Johnson & Johnson (JNJ), Sarepta Therapeutics Inc (SRPT), Edwards Lifesciences Corp (EW): 3 Health Care Investment Ideas for June
If you heeded the old adage to "sell in May and go away" this year, you're probably second-guessing your decision now.
Posts Tagged ‘Johnson & Johnson (JNJ)’
Johnson & Johnson (JNJ): A Dividend Watchlist for the Pullback
Over the last few years, investors have piled into high-quality dividend stocks in search of yield.
Prestige Brands Holdings, Inc. (PBH): An Above Average Company At Above Average Prices
You might have bought some of the over-the-counter (OTC) healthcare products that Prestige Brands Holdings, Inc.
Three Things About to Move Johnson & Johnson (JNJ) Stock
Johnson & Johnson (NYSE:JNJ) may be involved in everything from hip implants to pharmaceuticals, but it's the latter that brings in the majority of the profits and fuels any...
Consolidated Edison, Inc. (ED), Dominion Resources, Inc. (D), Public Service Enterprise Group Inc. (PEG): After A Utility Sell-Off These Three Stocks Could Be Next
This should not come as a complete surprise given the defensive nature of the industry.
Dendreon Corporation (DNDN): This Cancer Drug Developer Could Really Use a Partner
As we've learned over the past few years, getting a drug approved by the Food and Drug Administration is just half the battle in the biotech sector.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): The 7 Most Obese U.S. States
The U.S., which ranks as the most obese nation in the world according to the Organization for Economic Cooperation and Development, has seen a relatively steady increase over ...
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): 5 Costliest Microbes in Financial History
The field of synthetic biology is still in its infancy, with many of the most promising companies residing outside of public markets, but make no mistake: The bioeconomy is on...
Pfizer Inc. (PFE), Johnson & Johnson (JNJ), AT&T Inc. (T): These 4 Dow Stocks Return the Most Money to Shareholders
Companies in the Dow Jones Industrials typically have not only solid profits but also create immense amounts of cash flow, much of which they turn around and return to investors...
Johnson & Johnson (JNJ) Takes a Breather
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
The Long-Term Implications of Today’s Dow Jones Industrial Average (.DJI) Drop
In the context of the 2,700-point advance we've seen in the Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI) since this time last year, this morning's 150-point drop is only...
Why Baxter International Inc. (BAX) Is Soaring Despite Alzheimer’s Disappointment
Earlier this month, Baxter International Inc. (NYSE:BAX) reported that the clinical trials for the treatment of Alzheimer’s disease (Gammagard) had failed.
Merck & Co., Inc. (MRK): New Sleeping Aid Could Be an Awakening for This Pharma Giant
A recent review published online in the journal, The Lancet, found nearly a quarter of all adults are unhappy with their sleep patterns.
Three Big Reasons to Own Johnson & Johnson (JNJ) Stock
When investors are looking to fill out their retirement portfolios, they would be wise to give a long, hard look at Johnson & Johnson (NYSE:JNJ) stock.
Apple Inc. (AAPL), Google Inc (GOOG) Among 2013’s Twelve Biggest Companies
With 2013’s second financial quarter nearing its end, it is high time we took a look at how Wall Street’s favorite stocks are faring out.
Will Pipeline Disasters Devour Eli Lilly & Co. (LLY) Stock?
Eli Lilly & Co. (NYSE:LLY) investors just can't catch a break lately.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): The Top Three Causes of Diabetes
A whopping 25.3 million people in the U.S. right now are diabetic, with an additional 79 million Americans in the pre-diabetes stage.
McDonald’s Corporation (MCD), Johnson & Johnson (JNJ): More Danger Signs for the Market
Investors' total level of margin debt is less than half a percentage point below the record set in July 2007.
How Dividends Change the Game for Cisco Systems, Inc. (CSCO) Shareholders
The wealth-building power of compound interest will never cease to amaze me.
Amgen, Inc. (AMGN), Bristol Myers Squibb Co. (BMY): Can Financial Innovation Unlock a Cure for Cancer?
A few years ago, Andrew W. Lo from the MIT Sloan School of Management gave a lengthy talk at a meet-and-greet for prospective students of the Master of Finance program.
Johnson & Johnson (JNJ): Are Hedge Funds Right About This Stock?
If you'd ask most traders, hedge funds are viewed as unimportant, old investment tools of the past.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Is There Growth Left in Massive Drug Stocks?
In an already massive market segment, are dividends all you can hope for when you hunt down "elephants" like Warren Buffett does? While you probably won't get a five-bagger at...
Johnson & Johnson (JNJ), Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV): Watch This HCV Player
Johnson & Johnson (NYSE:JNJ)'s hepatitis C drug, simeprevir, recently received Priority Review status from the FDA.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): The Surprising Link Between ADHD and Obesity
The study tracked men with ADHD for more than 30 years and found that a whopping 41% of them were obese compared to 22% of patients in a matched control group who didn't have ...
Pfizer Inc. (PFE) Stock Checkup for May
We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay.
Will This Crush Medtronic, Inc. (MDT)’s Earnings?
On Tuesday, Medtronic, Inc. (NYSE:MDT) will release its latest quarterly results.
Intel Corporation (INTC), Johnson & Johnson (JNJ): This 10-Stock Dividend Strategy Is Trouncing the Dow Jones Industrial Average (.DJI)
The "Dogs of the Dow" strategy is one of the simplest for beating the market.
Baxter International Inc. (BAX), Eli Lilly & Co. (LLY): Diagnosing Alzheimer’s First
Alzheimer's is a debilitating neurodegenerative disorder affecting approximately 5 million Americans, yet its causes are remarkably enigmatic. Nonetheless, pharma and biotech...
AbbVie Inc (ABBV), The Dow Chemical Company (DOW), Texas Instruments Incorporated (TXN): A Quick Look at Avalon Advisor’s Big Buys Last Quarter
The 5 big buys of Avalon Advisors in the first quarter of 2013 are AbbVie Inc (NYSE:ABBV), The Dow Chemical Company (NYSE:DOW), Texas Instruments Incorporated (NASDAQ:TXN) , Johnson...
Wal-Mart Stores, Inc. (WMT), Johnson & Johnson (JNJ): Building An Income Fortress With Dividends Part II
As promised at the end of Part I of this two-part article, in Part II, I am presenting three more selections that will help investors round out a well-diversified, income-producing...
The Procter & Gamble Company (PG), Johnson & Johnson (JNJ): Billionaire Bill Ackman, CEO’s Clock Is Ticking
Billionaire Bill Ackman of Pershing Square Capital has been calling for the turnaround of the mega-cap consumer products company The Procter & Gamble Company (NYSE:PG) for some...
Buying Pfizer Inc. (PFE)’s History
Pfizer Inc. (NYSE:PFE) stock has been a boon for growth investors over the past year.
McDonald’s Corporation (MCD), Rio Tinto plc (ADR) (RIO), Syngenta AG (ADR) (SYT), BP plc (ADR) (BP): Billionaire Ken Fisher Boosts His Stake in These 4 Dividend Stocks
Billionaire Ken Fisher’s Fisher Asset Management has filed its quarterly 13F disclosure with the SEC, presenting its portfolio of equity holdings as of the end of the March ...
UnitedHealth Group Inc. (UNH), Aetna Inc. (AET): The Eight Biggest Health Problems Americans Face
The Centers for Disease Control and Prevention would put heart disease at the top of the list, since it's the leading cause of death in the nation.
Johnson & Johnson (JNJ): What You Should Know
Consider how big currency issues were in Europe alone (emphasis mine): "Sales in Europe experienced a decline of 1.1% as compared to the prior year, including operational growth...
Merck & Co., Inc. (MRK): Big Payout, Little Flexibility
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks.
Hewlett-Packard Company (HPQ), Verizon Communications Inc. (VZ): These 10 Stocks Are Outshining the Dow Jones Industrial Average (.DJI)
"Dogs of the Dow" refers to one of the simplest dividend strategies to beat the market.
Pfizer Inc. (PFE), Cisco Systems, Inc. (CSCO) & Billionaire Ken Fisher’s +3% Yielders
In early April, billionaire Ken Fisher’s Fisher Asset Management filed its 13F with the SEC, disclosing many of its long equity positions as of the end of March.
Allergan, Inc. (AGN): Is It Worth Looking At?
Allergan, Inc. (NYSE:AGN) has been consistently increasing on the market since the market bottom, from nearly $32 per share in November 2008 to more than $116 per share in ...
Dendreon Corporation (DNDN) Searching For A Rebound
Where have we heard the fourth-quarter-comeback plan before? Oh yes, from Johnson's predecessor who issued 2011 revenue guidance of $350 million to $400 million, with half of ...
United Online, Inc. (UNTD), Pfizer Inc. (PFE): On This Day In Business-Econ History…
The first official recognition of Mother's Day occurred nearly a century ago, when on May 9, 1914, President Woodrow Wilson proclaimed the second Sunday in May would thereafter...
What’s Buffett Think Of Johnson & Johnson (JNJ) and The Procter & Gamble Company (PG)?
The answer, of course, depends on who is asking.
MAKO Surgical Corp. (MAKO): It’s OK, You Can Exhale Now
Shares of the robotic surgery specialist traded up more than 4% after the company reported earnings yesterday.
AT&T Inc. (T), Johnson & Johnson (JNJ), Microsoft Corporation (MSFT): Should You Invest In These Blue Chips?
When screening for investments, I often like to look at the forward price-to-earnings ratio as a metric that gives me an estimated glimpse into a company's future earnings power...
Kimberly Clark Corp (KMB), And Three Reasons to Pick This Personal Care Stock
Kimberly Clark Corp (NYSE:KMB) is one of those few stocks that doesn’t need any buzz to outperform the market.
The Procter & Gamble Company (PG): The Hedge Fund Trade
The Procter & Gamble Company (NYSE:PG) saw a 5% plus pullback in its stock last week after reporting unimpressive quarterly results; however, this consumer-products giant owns...
Amgen, Inc. (AMGN), Johnson & Johnson (JNJ): Boom Or Ticking Time Bomb?
Reaching the coveted $1 billion mark in annual sales is no small feat for a drug.
Hedge Fund News: John Paulson, David Einhorn, Apple Inc. (AAPL)
Editor's Note: Related Tickers: Apple Inc. (NASDAQ:AAPL), The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), Citigroup Inc. (NYSE:C), Trinity Industries, Inc.
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count).
